Cancer Immunotherapy Market

The cancer immunotherapy market involves treatments that use the body's immune system to fight cancer. Key customers are hospitals, clinics, and cancer research centers. The market's growth is driven by the increasing incidence of cancer, significant R&D activities leading to more effective and targeted therapies, and recent breakthroughs in immunology.

CAGR

11.9%

Compound Annual Growth Rate

Current Value

$273.8B

Estimated 2026

Projected Value

$673.1B

By 2034